Cure8 research brief
Surveillance colonoscopies in IBD are meant to detect dysplasia or cancer; this report shows some solitary polyps may be benign retention polyps. Correct endoscopic removal and pathology spare patients from unnecessary alarm and help guide follow-up.
Adult IBD patients undergoing colonoscopic surveillance; gastroenterologists and pathologists involved in IBD care.
A 42-year-old man with 9 years of ulcerative colitis in clinical and endoscopic remission (Mayo endoscopic score 1) on mesalamine had a 15 mm sessile, smooth cystic polyp found on routine surveillance colonoscopy. The lesion was removed by endoscopic mucosal resection (EMR) and pathology showed a retention (juvenile-type) polyp without dysplasia or cancer.
The report emphasizes considering retention polyps in the differential for solitary polyps in adult IBD patients and the importance of complete endoscopic removal and careful histopathologic assessment to exclude dysplasia.
Structured content depth: abstract — the classification and brief are based on the article abstract provided by the journal. This is a single case report, which illustrates a rare finding but does not change surveillance guidelines. Retention polyps in adults are uncommon; final diagnosis relies on histopathology.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Coexistence of ulcerative colitis and collagenous colitis is rare but can change diagnosis and management. Stool calprotectin and biopsies helped identify and monitor disease activity, and adjusting mesalazine coincided...
Mesalamine can rarely cause myocarditis, creating a challenge for ongoing UC treatment. This report shows upadacitinib was used successfully as an alternative when biologics were considered higher cardiac risk and...
This trial tests whether an oral S1P modulator (etrasimod) is more effective than standard mesalazine for inducing remission in adults with active UC — a question that could affect initial treatment choices in China.
